Home
Conditions
Unspecified Adult Solid Tumor, Protocol Specific

Clinical trial condition

Unspecified Adult Solid Tumor, Protocol Specific

Explore clinical trials studying Unspecified Adult Solid Tumor, Protocol Specific. Study availability and eligibility vary by location and protocol.

616 public trials 6 recruiting studies

Refine in advanced search Browse all conditions

Unspecified Adult Solid Tumor, Protocol Specific trial results

Completed

Chemotherapy and Amifostine in Treating Patients With Recurrent or Refractory Solid Tumors

NCT00003144

Conditions: Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Drug/Agent Toxicity by Tissue/Organ, +1 more
Locations: NYU School of Medicine's Kaplan Comprehensive Cancer Center New York, United States

View Trial Details

Completed

Vaccine Therapy, Interleukin-2, and Sargramostim in Treating Patients With Advanced Tumors

NCT00003125

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +30 more
Locations: Lombardi Cancer Center, Georgetown University Washington D.C., District of Columbia, United States

National Naval Medical Center Bethesda, Maryland, United States

View Trial Details

Completed

VX-853 in Treating Patients With Solid Tumors Who Are Receiving Liposomal Doxorubicin

NCT00004030

Conditions: Unspecified Adult Solid Tumor, Protocol Specific
Locations: Vincent T. Lombardi Cancer Research Center, Georgetown University Washington D.C., District of Columbia, United States

View Trial Details

Completed

Epirubicin Plus Irinotecan in Treating Patients With Advanced Cancer

NCT00020748

Conditions: Unspecified Adult Solid Tumor, Protocol Specific
Locations: Lombardi Cancer Center at Georgetown University Medical Center Washington D.C., District of Columbia, United States

View Trial Details

Completed

S-3304 in Treating Patients With Advanced Solid Tumors

NCT00033566

Conditions: Unspecified Adult Solid Tumor, Protocol Specific
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Completed

Anhydrovinblastine in Treating Patients With Advanced Recurrent Solid Tumors

NCT00003882

Conditions: Unspecified Adult Solid Tumor, Protocol Specific
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Completed

Thalidomide in Treating Patients With Chronic Graft-Versus-Host Disease Following Bone Marrow Transplant

NCT00003894

Conditions: Graft Versus Host Disease, Graft vs Host Disease, Immune System Diseases, +2 more
Locations: Arkansas Children's Hospital Little Rock, Arkansas, United States

University of Kansas Medical Center Kansas City, Kansas, United States

Louisiana State University School of Medicine New Orleans, Louisiana, United States

Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Completed

Irinotecan Followed by Fluorouracil in Treating Patients With Advanced Solid Tumors

NCT00024141

Conditions: Unspecified Adult Solid Tumor, Protocol Specific
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Completed

Chemotherapy Given With Amifostine and Filgrastim in Treating Patients With Recurrent or Metastatic Cancer

NCT00003294

Conditions: Blast Crisis, Bone Marrow Diseases, Burkitt Lymphoma, +51 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Completed

KX2-391 in Treating Patients With Advanced Solid Tumors or Lymphoma That Did Not Respond to Treatment

NCT00646139

Conditions: Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +53 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Unspecified Adult Solid Tumor, Protocol Specific

Unspecified Adult Solid Tumor, Protocol Specific trial results

Related conditions